Intelligence · Clinical Pipeline
Infectious disease R&D Pipeline
Antiviral, antibacterial, and infectious disease vaccine pipeline programs.
- Programs
- 1,126
Quick answer
Infectious disease: NovaPharmaNews indexes 1,126 infectious disease clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Antiviral, antibacterial, and infectious disease vaccine pipeline programs.
Top sponsors
- United Therapeutics Europe 94 programs
- BRIGHT MINDS BIOSCIENCES 81 programs
- Chinese Academy of 77 programs
- Sinovac Research and 49 programs
- GSK Glaxo Smith 40 programs
- Takeda 35 programs
- First People's Hospital 31 programs
- Vertex Pharmaceuticals (Australia) 30 programs
- George Institute for 26 programs
- Vir Biotechnology 26 programs
- Anaxis Pharma 22 programs
- ENANTA PHARMACEUTICALS 22 programs
-
ARO-HSD Injection
Arrowhead Pharmaceuticals Ireland Limited
Non-alcoholic Steatohepatitis
1 trial -
ASC22
The First People's Hospital of Lianyungang
Chronic Hepatitis b
1 trial -
AT-527
Atea Pharmaceuticals
Hepatitis C
1 trial -
AT-527
Atea Pharmaceuticals
COVID-19
2 trials -
AT-777
Atea Pharmaceuticals
Hepatitis C
1 trial -
AVI-4065 Injection
Sarepta Therapeutics
Hepatitis C
1 trial -
Alvelestat
Mereo BioPharma Group plc
Covid19
1 trial -
Analogs, Prostaglandin E1
Vera Therapeutics
Covid19
1 trial -
Anti-PD-1 antibody
The First People's Hospital of Lianyungang
Chronic Hepatitis b
1 trial -
Antibody UB-421
United Therapeutics Europe Ltd
HIV-1 Infection in Adults
1 trial -
Aprepitant injectable emulsion
Heron Therapeutics
COVID-19
1 trial -
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial -
BEVACIZUMAB
Pari Pharma GmbH
Adult patients with persistent dyspnea more than 3 months after acute COVID-19 infection.
1 trial -
BMS-955176
ViiV Healthcare B.V.
HIV Infections
1 trial -
BRII-179
Vir Biotechnology
For Treatment of Chronic Hepatitis B Virus Infection
1 trial -
BRII-835 (VIR-2218)
Vir Biotechnology
Hepatitis B, Chronic
1 trial -
Bacteriophage
Adaptive Biotechnologies Corp
Prosthetic Joint Infection
1 trial -
Bacteriophage Therapy
Adaptive Biotechnologies Corp
Urinary Tract Infection Bacterial
1 trial -
Bamlanivimab
Vir Biotechnology
COVID-19
1 trial -
Behavior Therapy
BRIGHT MINDS BIOSCIENCES INC.
The Study Was Designed to Develop a Cognitive Behavioral Approach to Treating Methamphetamine Abuse in HIV Primary Care Settings
1 trial -
Behavioral Drug and Risk Counseling (BDRC)
BRIGHT MINDS BIOSCIENCES INC.
HIV Risk Behaviors
1 trial -
Bemnifosbuvir
Atea Pharmaceuticals
Chronic Hepatitis C Virus
1 trial -
Benznidazole
BRIGHT MINDS BIOSCIENCES INC.
Trypanosoma Cruzi Infection
1 trial -
Bisphosphocin Nu-3
Lakewood-Amedex Biotherapeutics
Diabetic Foot Infections
1 trial -
Bovine colostrum
Hospital Authority, Hong Kong
Severe Alcoholic Hepatitis in 'Extremis'- Defined by mDF>54
1 trial -
Brincidofovir
Jazz Pharmaceuticals Ireland Limited
Cytomegalovirus Infection
1 trial -
Budigalimab, Placebo for Budigalimab (ABBV-181) - 0.9% Sodium Chloride or DILUENT, ABBV-382, Placebo for ABBV-382 Solution for Infusion
AbbVie Deutschland GmbH & Co. KG
HIV infection
1 trial -
Buffer S9b Solution for suspension for injection
GlaxoSmithKline
Hepatitis B, Chronic
1 trial -
Buffer S9b Solution for suspension for injection
GlaxoSmithKline
Hepatitis B, Chronic
1 trial -
BufferGel
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Busulfan Koanaa 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung, GRANOCYTE 34 Millions UI/ml, poudre et solvant pour solution injectable / perfusion, Autologous CD34+ cells transduced with lentiviral vector encoding the human beta-globin gene, Plerixafor Accord 20 mg/ml solution for injection
Fondazione Telethon ETS
transfusion-dependent beta-thalassemia
1 trial -
CAP-1002
CAPRICOR THERAPEUTICS, INC.
Covid19
1 trial -
CERC-002
Avalo Therapeutics
COVID-19 Pneumonia
1 trial -
CF 102
Can-Fite BioPharma
Chronic Hepatitis C
1 trial -
CF102
Can-Fite BioPharma
Non-alcoholic Steatohepatitis (NASH)
1 trial -
CHRONVAC-C®
INOVIO PHARMACEUTICALS, INC.
Chronic Hepatitis C Virus Infection
1 trial -
COVAXIN(BBV152)
Biotech Pharmaceutical Co.,
Corona Virus Infection
1 trial -
COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose)
Sinovac Research and Development Co.,
COVID-19
1 trial -
COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
Sinovac Research and Development Co.,
COVID-19
1 trial -
COVID-19 Vaccine HIPRA
Hipra Human Health S.L.
COVID-19
1 trial -
CP101
Finch Therapeutics Group
Clostridium Difficile Infection
1 trial -
CRV431 75mg
Hepion Pharmaceuticals
NASH - Nonalcoholic Steatohepatitis
1 trial -
CSG452 (Tofogliflozin) placebo, pemafibrate, K-877 ER (Pemafibrate) placebo, TOFOGLIFLOZIN
The George Institute
Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis
1 trial -
CT-011
Teva Pharma GmbH
Chronic Hepatitis C
1 trial -
CYSTAGON 150 mg hard capsules
The George Institute
Infectious diseases of respiratory system (COVID-19)
1 trial -
Cefiderocol
Shionogi B.V.
Gram-negative Bacterial Infections
1 trial -
Ceftriaxone 1000mg + doxycycline 100 mg
Hong Kong Baptist University
Neisseria Gonorrhoeae Infection
1 trial -
Cemiplimab
Regeneron UK Limited
Hepatitis B Virus
1 trial
Frequently asked questions
How many infectious disease pipeline programs are tracked?
1,126 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.
Data attribution: Data sources · All pipeline programs